Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
- PMID: 1525830
- DOI: 10.1016/0092-8674(92)90244-7
Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
Abstract
Loss of cell cycle control and acquisition of chromosomal rearrangements such as gene amplification often occur during tumor progression, suggesting that they may be correlated. We show here that the wild-type p53 allele is lost when fibroblasts from patients with the Li-Fraumeni syndrome (LFS) are passaged in vitro. Normal and LFS cells containing wild-type p53 arrested in G1 when challenged with the uridine biosynthesis inhibitor PALA and did not undergo PALA-selected gene amplification. The converse occurred in cells lacking wild-type p53 expression. Expression of wild-type p53 in transformants of immortal and tumor cells containing mutant p53 alleles restored G1 control and reduced the frequency of gene amplification to undetectable levels. These studies reveal that p53 contributes to a metabolically regulated G1 check-point, and they provide a model for understanding how abnormal cell cycle progression leads to the genetic rearrangements involved in tumor progression.
Similar articles
-
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.Cell. 1992 Sep 18;70(6):923-35. doi: 10.1016/0092-8674(92)90243-6. Cell. 1992. PMID: 1356076
-
Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.Oncogene. 1996 Jun 6;12(11):2267-78. Oncogene. 1996. PMID: 8649766 Free PMC article.
-
Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition?Oncogene. 1997 Jan 23;14(3):277-82. doi: 10.1038/sj.onc.1200838. Oncogene. 1997. PMID: 9018113
-
Genomic integrity and the genetics of cancer.Cold Spring Harb Symp Quant Biol. 1994;59:265-75. doi: 10.1101/sqb.1994.059.01.031. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587078 Review. No abstract available.
-
[p53 transgenic and knockout mice].Nihon Rinsho. 2000 Jun;58(6):1250-4. Nihon Rinsho. 2000. PMID: 10879049 Review. Japanese.
Cited by
-
What We Know about the Molecular Genetics of Central Nervous System (CNS) Tumours in Malaysia.Malays J Med Sci. 2004 Jan;11(1):37-43. Malays J Med Sci. 2004. PMID: 22977358 Free PMC article.
-
Complete Models of p53 Better Inform the Impact of Hotspot Mutations.Int J Mol Sci. 2022 Dec 3;23(23):15267. doi: 10.3390/ijms232315267. Int J Mol Sci. 2022. PMID: 36499604 Free PMC article.
-
Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.Mol Cell Biol. 2000 Nov;20(21):8018-25. doi: 10.1128/MCB.20.21.8018-8025.2000. Mol Cell Biol. 2000. PMID: 11027272 Free PMC article.
-
Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14949-54. doi: 10.1073/pnas.96.26.14949. Proc Natl Acad Sci U S A. 1999. PMID: 10611318 Free PMC article.
-
Homologous Recombination and Its Role in Carcinogenesis.J Biomed Biotechnol. 2002;2(2):75-85. doi: 10.1155/S1110724302204052. J Biomed Biotechnol. 2002. PMID: 12488587 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous